LABORATORY NEWS
-
Prometheus Laboratories Announces New Health Plan Agreements To Provide Precision-Guided Testing Services
Prometheus Laboratories Inc. ("Prometheus"), a leader in precision medicine for immune-mediated diseases, announced the execution of provider agreements with three large regional health plans to facilitate access to PredictrPK, precision-guided biologic testing, and other Prometheus testing services to the participating health plans and their respective members.
- ADLM Releases Guidance To Help Healthcare Professionals Navigate Respiratory Virus Testing In A Post-COVID World
- Indica Labs Receives First FDA Clearance For HALO AP Dx Digital Pathology Platform
- Orchard Software Partners With Luxor Scientific To Expand Testing Services
- Biolabs International LLC Announces Exclusive Distribution Agreement With Watmind USA™ For Next-Generation Diagnostics Platform
ARCHIVED NEWSLETTER
- 04.23.24 -- FDA Warns Industry Of Fraudulent & Unreliable Lab Testing Data In Premarket Submissions
- 04.09.24 -- Pivoting To Allogeneic CAR-T Therapies With Celyad Oncology's CMO, Dr. Charlie Morris
- 03.26.24 -- Notable Public Comments On The FDA's Proposed Regulation For Laboratory Developed Tests
- 03.12.24 -- FDA's CBER Issues Final Guidance For CAR T Cell Products
- 02.27.24 -- FDA Issues Final Guidance: Reformulating Drug Products That Contain Carbomers Manufactured With Benzene
This website uses cookies to ensure you get the best experience on our website. Learn more